EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity

Denise A Warzak, Whitney A Pike, Kyle D Luttgeharm

SLAS Technology · 2023

DOI: 10.1016/j.slast.2023.06.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SLAS Technology, 2023. Verfasst von Denise A Warzak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Agilent Technologies, Ankeny, IA 50023, USA. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Pandemics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One result of the Covid-19 pandemic has been an increased awareness of IVT mRNA vaccines and the speed at which they can be produced for disease outbreaks. Currently the only approved IVT mRNA therapeutics are the Covid-19 vaccines, however IVT mRNA is being investigated for other non-Covid prophylactic vaccines, therapeutics, and therapeutic vaccines. IVT mRNAs can range from less than 100 nt in length to longer than 9,000 nt. When producing any IVT mRNA, quality control of the IVT mRNA is essential to ensure that the product is the correct length and does not contain truncated or degraded mRNA. Capillary gel electrophoresis provides high resolution separations of the IVT mRNA of interest from the degraded or truncated impurities allowing for the accurate purity assessment of IVT mRNA. Specialized capillary electrophoresis gels can also be used to provide analysis of purified poly(A) tails enabling characterization of multiple Critical Quality Attributes on a single platform. Here we describe methods for the purity assessment of IVT mRNAs through either 6,000 or 9,000 nt and determination of poly(A) tail length using different capillary gel electrophoresis methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesPandemicsHumansRNA, MessengerElectrophoresis, Capillary

Stichwörter der Autor:innen

Capillary gel electrophoresisCovid-19 vaccineIVT mRNAmRNA critical quality attributemRNA puritymRNA therapeuticmRNA vaccine

Substanzen

RNA, MessengerCOVID-19 Vaccines

Autor:innen und Institutionen

  • Agilent Technologies, Ankeny, IA 50023, USA.
  • Agilent Technologies, Ankeny, IA 50023, USA. Electronic address: kyle.luttgeharm@agilent.com.

Zitieren

APA

Warzak, D. A., Pike, W. A., & Luttgeharm, K. D. (2023). Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity. SLAS Technology. https://doi.org/10.1016/j.slast.2023.06.005

Vancouver

Warzak DA, Pike WA, Luttgeharm KD. Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity. SLAS Technology. 2023. doi:10.1016/j.slast.2023.06.005

BibTeX
@article{Warzak2023,
  author = {Warzak, Denise A and Pike, Whitney A and Luttgeharm, Kyle D},
  title = {Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity},
  journal = {SLAS Technology},
  year = {2023},
  doi = {10.1016/j.slast.2023.06.005}
}
Kostenlos starten →